SynthesisBMC infectious diseases2011
Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review.
Synthesis in BMC infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.
- Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.BMC infectious diseases · 2013Pooled it
- Liver fibrosis severity in chronic hepatitis B is associated with area-level rather than individual socioeconomic disadvantage: a nationwide multicentre study in Türkiye.Infectious diseases of poverty · 2026Observational
- Hepatitis B in Isolated Anti-HBc Carriers: Predictors of Detectable HBV DNA and Implications for Risk-Stratified Screening.Viruses · 2026Article
- A 23-Year Comprehensive Analysis of over 4000 Liver Transplants in Türkiye: Integrating Clinical Outcomes with Public Health Insights.Healthcare (Basel, Switzerland) · 2026Article
- Shifts in liver biopsy indications and histopathological diagnoses: A report from a tertiary care center in Türkiye.Hepatology forum · 2026Article
- A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025Article
- Hepatitis delta virus infection in Turkey: A meta-analysis of prevalence.IJID regions · 2024Article
- Change in Rates of HBsAg and Anti-HBs in Şırnak 20 Years After Introduction of Hepatitis B Vaccine into Routine Infant Immunization Program.Infectious diseases & clinical microbiology · 2023Article
- Phylogenetic analysis and prevalence of Delta hepatitis among HBsAg carriers in Afghanistan.Molecular biology research communications · 2022Article
- Gene therapy in haemophilia: literature review and regional perspectives for Turkey.Therapeutic advances in hematology · 2022Review
- Healthcare students' vaccination status, knowledge, and protective behaviors regarding hepatitis B: a cross-sectional study in Turkey.Human vaccines & immunotherapeutics · 2021Article
- Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2020Article
- Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study.BMC infectious diseases · 2020Article
- Prevalence of sexually transmitted infections among foreigners living in Guangzhou, China: a cross-sectional study (2010-2017).BMC infectious diseases · 2020Article
- Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infectionsBalkan medical journal · 2020Article
- Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium.PloS one · 2020Article
- HBsAg, Anti-HCV and Anti-HIV Seroprevalance Among Drug Users: a Retrospective Assessment.Noro psikiyatri arsivi · 2019Article
- Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening.Medicine · 2019Article
- Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers.Clinical and experimental nephrology · 2019Article
- Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study.BMC medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo provide a clear picture of the current hepatitis B situation, the authors performed a systematic review to estimate the age- and region-specific prevalence of chronic hepatitis B (CHB) in Turkey.
methodsA total of 339 studies with original data on the prevalence of hepatitis B surface antigen (HBsAg) in Turkey and published between 1999 and 2009 were identified through a search of electronic databases, by reviewing citations, and by writing to authors. After a critical assessment, the authors included 129 studies, divided into categories: 'age-specific'; 'region-specific'; and 'specific population group'. To account for the differences among the studies, a generalized linear mixed model was used to estimate the overall prevalence across all age groups and regions. For specific population groups, the authors calculated the weighted mean prevalence.
resultsThe estimated overall population prevalence was 4.57, 95% confidence interval (CI): 3.58, 5.76, and the estimated total number of CHB cases was about 3.3 million. The outcomes of the age-specific groups varied from 2.84, (95% CI: 2.60, 3.10) for the 0-14-year olds to 6.36 (95% CI: 5.83, 6.90) in the 25-34-year-old group.
conclusionThere are large age-group and regional differences in CHB prevalence in Turkey, where CHB remains a serious health problem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.